M. Iverson

Generation of a Humanized, High Affinity Anti-tissue Factor Antibody for Use as a Novel Antithrombotic Therapeutic

Y G Meng, L. Presta, R. Kelley, 2001, Thrombosis and Haemostasis.

Non-clinical immunological comparison of a Next-Generation 24-valent pneumococcal conjugate vaccine (VAX-24) using site-specific carrier protein conjugation to the current standard of care (PCV13 and PPV23).

N. Kapoor, T. Migone, J. Wassil, 2021, Vaccine.

Addition of Lauryldimethylamine N-Oxide (LDAO) to a Copper-Free Click Chemistry Reaction Improves the Conjugation Efficiency of a Cell-Free Generated CRM197 Variant to Clinically Important Streptococcus pneumoniae Serotypes

Shylaja Arulkumar, N. Kapoor, J. Fairman, 2022, ACS omega.